Trang kết quả 13 cho Khu vực: Chăm sóc sức khỏe Ngành: Công nghệ sinh học Thị trường chứng khoán - Báo giá & giá
Danh sách tất cả các chứng khoán và vốn chủ sở hữu kèm giá, vốn hoá thị trường, PE và EPS
Tất cả các quốc gia
- {{country.name}}
- Tất cả các quốc gia
- Hoa Kỳ (1012)
- Úc (57)
- Áo (16)
- Bỉ (7)
- Brazil (16)
- Canada (83)
- Trung Quốc (93)
- Đan Mạch (6)
- Phần Lan (4)
- Pháp (41)
- Đức (739)
- Hồng Kông (46)
- Ấn Độ (19)
- Ai-len (1)
- Israel (19)
- Ý (4)
- Nhật Bản (37)
- Mexico (28)
- Hà Lan (3)
- New Zealand (1)
- Na Uy (15)
- Ba Lan (9)
- Nga (2)
- Hàn Quốc (20)
- Tây Ban Nha (4)
- Thụy Điển (70)
- Thụy Sĩ (11)
- Đài Loan (67)
- Thái Lan (2)
- Thổ Nhĩ Kỳ (1)
- Vương quốc Anh (68)
Tất cả các sàn giao dịch
- {{item.name}}
- Tất cả các sàn giao dịch
- Amsterdam (3)
- ASX (57)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KOSDAQ (10)
- KSE (10)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- NSE (10)
- NYSE (11)
- NYSE American (18)
- NYSEArca (1)
- NZSE (1)
- Oslo (15)
- OTC Markets EXMKT (128)
- OTC Markets OTCPK (123)
- OTC Markets OTCQB (35)
- OTC Markets OTCQX (7)
- Other OTC (39)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (46)
- Stockholm (70)
- Stuttgart (39)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tech Market Large (212)
- Tech Market Middle (139)
- Tech Market Small (299)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (24)
Chăm sóc sức khỏe (2616)
- {{item.name}}
- Tất cả các khối
- Chăm sóc sức khỏe (2616)
Công nghệ sinh học (2616)
- {{item.name}}
- Tất cả các ngành
- Công nghệ sinh học (2616)
- Nhà sản xuất thuốc - Chung (243)
- Nhà sản xuất thuốc - Biệt dược & Thuốc gốc (1531)
- Gói y tế (56)
- Cơ sơ chăm sóc y tế (555)
- Nhà bán lẻ thuốc (156)
- Dịch vụ thông tin sức khỏe (422)
- Thiết bị y tế (922)
- Thiết bị & nguồn cung y tế (504)
- Chẩn đoán & nghiên cứu (429)
- Phân phối y tế (141)
| Tên Tên | Giá Giá |
% 24h Biểu đồ 7n 24h% & 7n |
Vốn hoá TT Vốn hóa thị trường | KH. LƯỢNG Khối lượng | Đáy 24h | Đỉnh 24h | Vốn hóa thị trường | Tỉ lệ P/E | EPS |
|---|
| Tên Tên | Giá Giá |
% 24h Biểu đồ 7n 24h% & 7n |
Vốn hoá TT Vốn hóa thị trường | KH. LƯỢNG Khối lượng | Đáy 24h | Đỉnh 24h | Vốn hóa thị trường | Tỉ lệ P/E | EPS | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| CorMedix Inc. 19KA.F | €9.70 10.6 USD |
-1.02
|
€759.99M 830.77M USD | €1.00K 1.09K USD | €9.70 10.6 USD | €9.70 10.6 USD | €759.99M 830.77M USD | 14.47 | €0.67 0.73 USD | |
| GNI Group Ltd. 3G6.F | €13.60 14.87 USD |
-0.73
|
€755.55M 825.92M USD | €500.00 546.57 USD | €13.60 14.87 USD | €13.60 14.87 USD | €755.55M 825.92M USD | 0 | -€0.02 -0.02 USD | |
| Pharmicell Co., Ltd. 005690.KS | ₩17,910 13.52 USD |
-1.97
|
₩1T 811.2M USD | ₩4M 3.13K USD | ₩17,750 13.4 USD | ₩19,290 14.56 USD | ₩1T 811.2M USD | 0 | ₩0 0 USD | |
| Supriya Lifescience Limited SUPRIYA.BO | ₹787.35 9.53 USD |
+3.4
|
₹64.55B 780.9M USD | ₹44.31K 536.09 USD | ₹767.45 9.28 USD | ₹823.30 9.96 USD | ₹64.55B 780.9M USD | 35.53 | ₹22.16 0.27 USD | |
| Supriya Lifescience Limited SUPRIYA.NS | ₹786.70 9.52 USD |
+3.19
|
₹64.41B 779.28M USD | ₹1.43M 17.25K USD | ₹766.20 9.27 USD | ₹823.25 9.96 USD | ₹64.41B 779.28M USD | 35.58 | ₹22.11 0.27 USD | |
| Savara Inc. YB4P.F | €3.50 3.83 USD |
-1.69
|
€704.56M 770.18M USD | €279.00 304.98 USD | €3.50 3.83 USD | €3.50 3.83 USD | €704.56M 770.18M USD | 0 | -€0.44 -0.4 USD | |
| Valneva SE INRLF | $4.40 — |
0
|
$762.59M — | $175.00 — | $4.40 — | $4.40 — | $762.59M — | 0 | -$0.53 — | |
| Geron Corporation GON.F | €1.06 1.16 USD |
-2.48
|
€677.61M 740.72M USD | €1.00K 1.09K USD | €1.06 1.16 USD | €1.06 1.16 USD | €677.61M 740.72M USD | 0 | -€0.10 -0.1 USD | |
| Replimune Group, Inc. 7R8.F | €7.65 8.36 USD |
-0.65
|
€652.08M 712.82M USD | €200.00 218.63 USD | €7.65 8.36 USD | €7.65 8.36 USD | €652.08M 712.82M USD | 0 | -€2.99 -3.2 USD | |
| Valneva SE AYJ0.F | €7.15 7.82 USD |
-6.54
|
€648.77M 709.19M USD | €350.00 382.6 USD | €7.00 7.65 USD | €7.15 7.82 USD | €648.77M 709.19M USD | 0 | -€0.92 -1.005 USD | |
| Takara Bio Inc. TF2.F | €4.42 4.83 USD |
+3.76
|
€647.49M 707.79M USD | €200.00 218.63 USD | €4.42 4.83 USD | €4.42 4.83 USD | €647.49M 707.79M USD | 0 | -€0.30 -0.3 USD | |
| Sunmax Biotechnology Co., Ltd. 4728.TWO | NT$403.00 12.81 USD |
+1.26
|
NT$21.95B 697.42M USD | NT$3.08K 97.9 USD | NT$400.00 12.71 USD | NT$403.00 12.81 USD | NT$21.95B 697.42M USD | 31.43 | NT$12.82 0.41 USD | |
| Takara Bio Inc. 4974.T | ¥833 5.62 USD |
+1.34
|
¥100B 677.09M USD | ¥556K 3.75K USD | ¥820 5.54 USD | ¥847 5.72 USD | ¥100B 677.09M USD | 0 | -¥53 -0.3 USD | |
| CytomX Therapeutics, Inc. 6C1.F | €3.59 3.92 USD |
+3.16
|
€607.93M 664.55M USD | €1.35K 1.48K USD | €3.59 3.92 USD | €3.59 3.92 USD | €607.93M 664.55M USD | 13.80 | €0.26 0.28 USD | |
| Gossamer Bio, Inc. 4GB.MU | €2.29 2.5 USD |
+4.19
|
€607.25M 663.81M USD | €0.00 0 USD | €2.29 2.5 USD | €2.29 2.5 USD | €607.25M 663.81M USD | 0 | -€0.79 -0.8 USD | |
| Inventiva IVEVF | $4.44 — |
0
|
$647.76M — | $600.00 — | $4.14 — | $4.50 — | $647.76M — | 0 | -$4.36 — | |
| Viva Biotech Holdings VB0.F | €0.24 0.26 USD |
+0.85
|
€577.44M 631.22M USD | €5.78K 6.32K USD | €0.24 0.26 USD | €0.24 0.26 USD | €577.44M 631.22M USD | 23.60 | €0.01 0.01 USD | |
| Anavex Life Sciences Corp. 12X1.F | €5.82 6.36 USD |
-3.74
|
€569.49M 622.53M USD | €424.00 463.49 USD | €5.82 6.36 USD | €5.82 6.36 USD | €569.49M 622.53M USD | 0 | -€0.49 -0.5 USD | |
| KalVista Pharmaceuticals, Inc. 4XC1.F | €11.20 12.24 USD |
+15.46
|
€566.12M 618.84M USD | €930.00 1.02K USD | €11.20 12.24 USD | €11.20 12.24 USD | €566.12M 618.84M USD | 0 | -€3.40 -3.7 USD | |
| REGENXBIO Inc. RB0.F | €9.95 10.88 USD |
0
|
€557.47M 609.39M USD | €2.50K 2.73K USD | €9.95 10.88 USD | €9.95 10.88 USD | €557.47M 609.39M USD | 0 | -€2.99 -3.2 USD | |
| Inventiva S.A. 6IV.F | €3.24 3.54 USD |
+2.69
|
€539.24M 589.46M USD | €500.00 546.57 USD | €3.24 3.54 USD | €3.24 3.54 USD | €539.24M 589.46M USD | 0 | -€3.76 -4.1 USD | |
| Viva Biotech Holdings VBIZF | $0.26 — |
0
|
$589.02M — | $100.00 — | $0.30 — | $0.30 — | $589.02M — | 26.35 | $0.01 — | |
| Inventiva S.A. 6IVA.F | €3.24 3.54 USD |
+1.89
|
€535.00M 584.83M USD | €4.00K 4.37K USD | €3.24 3.54 USD | €3.26 3.56 USD | €535.00M 584.83M USD | 0 | -€3.76 -4.1 USD | |
| Opthea OPT | $3.41 — |
0
|
$583.10M — | $0.00 — | $3.41 — | $3.41 — | $583.10M — | 0 | -$2.25 — | |
| Green Cross Holdings Corporation 005250.KS | ₩16,860 12.73 USD |
+1.26
|
₩769B 580.83M USD | ₩179K 134.91 USD | ₩16,500 12.45 USD | ₩16,970 12.81 USD | ₩769B 580.83M USD | 0 | ₩0 0 USD | |
| Prestige BioPharma Limited 950210.KS | ₩12,790 9.65 USD |
+1.27
|
₩769B 580.19M USD | ₩163K 123.04 USD | ₩12,650 9.55 USD | ₩13,430 10.14 USD | ₩769B 580.19M USD | 0 | ₩0 0 USD | |
| Green Cross Holdings Corporation 005257.KS | ₩25,350 19.14 USD |
+1
|
₩767B 579.31M USD | ₩474 0.36 USD | ₩25,150 18.98 USD | ₩25,900 19.55 USD | ₩767B 579.31M USD | 0 | ₩0 0 USD | |
| Zota Health Care Limited ZOTA.NS | ₹1,539.80 18.63 USD |
+0.48
|
₹46.71B 565.07M USD | ₹48.87K 591.2 USD | ₹1,518.00 18.37 USD | ₹1,563.40 18.91 USD | ₹46.71B 565.07M USD | 0 | -₹21.46 -0.2 USD | |
| Opthea Limited UKJ2.F | €3.00 3.28 USD |
0
|
€512.99M 560.77M USD | €0.00 0 USD | €3.00 3.28 USD | €3.00 3.28 USD | €512.99M 560.77M USD | 0 | -€1.94 -2.1 USD | |
| Gossamer Bio, Inc. 4GB.F | €2.21 2.42 USD |
-0.63
|
€511.52M 559.16M USD | €100.00 109.31 USD | €2.21 2.42 USD | €2.21 2.42 USD | €511.52M 559.16M USD | 0 | -€0.60 -0.6 USD | |
| Niagen Bioscience, Inc. OCD1.F | €5.80 6.34 USD |
-1.69
|
€510.87M 558.45M USD | €1.20K 1.31K USD | €5.80 6.34 USD | €5.80 6.34 USD | €510.87M 558.45M USD | 27.61 | €0.21 0.23 USD | |
| Prothena Corporation plc 0PT.F | €9.25 10.11 USD |
+0.54
|
€502.81M 549.63M USD | €24.00 26.24 USD | €9.25 10.11 USD | €9.25 10.11 USD | €502.81M 549.63M USD | 0 | -€4.49 -4.9 USD | |
| Akebia Therapeutics, Inc. AX9.F | €1.59 1.74 USD |
-1.12
|
€500.73M 547.37M USD | €500.00 546.57 USD | €1.59 1.74 USD | €1.59 1.74 USD | €500.73M 547.37M USD | 0 | -€0.07 -0.07 USD | |
| NovaBridge Biosciences 0VY.F | €3.62 3.96 USD |
+1.12
|
€498.59M 545.03M USD | €4.45K 4.86K USD | €3.62 3.96 USD | €3.62 3.96 USD | €498.59M 545.03M USD | 0 | -€0.44 -0.4 USD | |
| Opthea Limited OPT.AX | A$0.60 0.4 USD |
0
|
A$820.79M 543.24M USD | A$6.21M 4.11M USD | A$0.60 0.39 USD | A$0.62 0.41 USD | A$820.79M 543.24M USD | 0 | -A$0.43 -0.2 USD | |
| Zevra Therapeutics, Inc. 1GDA.F | €8.00 8.75 USD |
-0.62
|
€490.78M 536.49M USD | €10.00 10.93 USD | €8.00 8.75 USD | €8.00 8.75 USD | €490.78M 536.49M USD | 19.51 | €0.41 0.45 USD | |
| NovaBridge Biosciences IMAB | $4.63 — |
0
|
$533.68M — | $0.00 — | $0.00 — | $0.00 — | $533.68M — | 0 | $0.00 — | |
| Dishman Carbogen Amcis Limited DCAL.BO | ₹246.50 2.98 USD |
-3.88
|
₹43.97B 531.92M USD | ₹11.12K 134.47 USD | ₹244.55 2.96 USD | ₹254.80 3.08 USD | ₹43.97B 531.92M USD | 28.26 | ₹8.72 0.11 USD | |
| Dishman Carbogen Amcis Limited DCAL.NS | ₹245.95 2.98 USD |
-4.06
|
₹43.89B 530.94M USD | ₹196.47K 2.38K USD | ₹242.10 2.93 USD | ₹256.50 3.1 USD | ₹43.89B 530.94M USD | 28.20 | ₹8.72 0.11 USD | |
| Bicycle Therapeutics plc 50BA.F | €5.45 5.96 USD |
-3.54
|
€466.65M 510.12M USD | €315.00 344.34 USD | €5.45 5.96 USD | €5.45 5.96 USD | €466.65M 510.12M USD | 0 | -€3.12 -3.4 USD | |
| Nxera Pharma Co., Ltd. JSS.F | €4.62 5.05 USD |
+1.76
|
€463.29M 506.44M USD | €400.00 437.25 USD | €4.62 5.05 USD | €4.62 5.05 USD | €463.29M 506.44M USD | 0 | -€0.20 -0.2 USD | |
| Nxera Pharma SOLTF | $5.50 — |
0
|
$497.72M — | $100.00 — | $6.40 — | $6.40 — | $497.72M — | 0 | -$0.23 — | |
| Altimmune, Inc. ALT1.MX | MX$78.70 4.66 USD |
0
|
MX$8.21B 486.24M USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$8.21B 486.24M USD | 0 | -MX$19.60 -1.1 USD | |
| Opthea Limited UKJ.F | €0.32 0.35 USD |
0
|
€437.75M 478.52M USD | €7.00K 7.65K USD | €0.32 0.35 USD | €0.32 0.35 USD | €437.75M 478.52M USD | 0 | -€0.25 -0.2 USD | |
| Omeros Corporation 3O8.F | €5.89 6.44 USD |
+0.34
|
€432.57M 472.86M USD | €3.32K 3.63K USD | €5.89 6.44 USD | €5.89 6.44 USD | €432.57M 472.86M USD | 0 | -€2.04 -2.2 USD | |
| DBV Technologies S.A. DBV.F | €2.34 2.55 USD |
-7.71
|
€419.70M 458.79M USD | €400.00 437.25 USD | €2.34 2.55 USD | €2.34 2.55 USD | €419.70M 458.79M USD | 0 | -€0.90 -0.9 USD | |
| Avacta AVCTF | $1.05 — |
0
|
$455.35M — | $26.00K — | $0.96 — | $1.05 — | $455.35M — | 0 | -$0.15 — | |
| Ocugen, Inc. OCGN.MX | MX$24.00 1.42 USD |
0
|
MX$7.61B 450.68M USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$7.61B 450.68M USD | 0 | -MX$4.03 -0.2 USD | |
| Bright Minds Biosciences Inc. DRUG.CN | CA$81.24 60.28 USD |
0
|
CA$575.88M 427.34M USD | CA$0.00 0 USD | CA$0.00 0 USD | CA$0.00 0 USD | CA$575.88M 427.34M USD | 0 | -CA$1.37 -1.01 USD | |
| Formycon AG FYB.F | €20.85 22.79 USD |
-2.8
|
€376.03M 411.05M USD | €598.00 653.69 USD | €20.85 22.79 USD | €21.50 23.5 USD | €376.03M 411.05M USD | 0 | -€9.67 -10.5 USD | |
| PureTech Health PRTC | $16.80 — |
+2.82
|
$410.72M — | $2.07K — | $16.25 — | $16.80 — | $410.72M — | 9.88 | $1.70 — | |
| PureTech Health PTCHF | $1.68 — |
0
|
$406.03M — | $1.00K — | $1.70 — | $1.70 — | $406.03M — | 9.88 | $0.17 — | |
| Avacta Group Plc RTQ1.F | €0.86 0.93 USD |
+5.56
|
€370.78M 405.32M USD | €6.00K 6.56K USD | €0.86 0.93 USD | €0.86 0.93 USD | €370.78M 405.32M USD | 0 | -€0.13 -0.1 USD | |
| Rocket Pharmaceuticals, Inc. 9IP1.F | €2.66 2.9 USD |
+4.81
|
€368.48M 402.8M USD | €7.90K 8.64K USD | €2.66 2.9 USD | €2.66 2.9 USD | €368.48M 402.8M USD | 0 | -€1.94 -2.1 USD | |
| PureTech Health plc 0VQ0.F | €13.10 14.32 USD |
0
|
€362.77M 396.56M USD | €0.00 0 USD | €13.10 14.32 USD | €13.10 14.32 USD | €362.77M 396.56M USD | 8.91 | €1.47 1.61 USD | |
| Autolus Therapeutics plc 6A3A.F | €1.16 1.27 USD |
+1.75
|
€362.75M 396.54M USD | €2.25K 2.46K USD | €1.16 1.27 USD | €1.16 1.27 USD | €362.75M 396.54M USD | 0 | -€0.75 -0.8 USD | |
| Oncoinvent ASA BRRGF | $2.50 — |
0
|
$391.60M — | $37.31K — | $0.03 — | $0.03 — | $391.60M — | 0 | -$5.26 — | |
| Antengene Corporation Limited 722.F | €0.52 0.56 USD |
+0.98
|
€355.44M 388.55M USD | €103.00 112.59 USD | €0.52 0.56 USD | €0.52 0.56 USD | €355.44M 388.55M USD | 0 | -€0.04 -0.04 USD | |
| Cellectis S.A. CMVLF | $5.04 — |
0
|
$379.70M — | $100.00 — | $4.26 — | $4.26 — | $379.70M — | 0 | -$0.33 — | |
| Clinuvel Pharmaceuticals CLVLF | $7.56 — |
0
|
$379.52M — | $100.00 — | $7.56 — | $7.56 — | $379.52M — | 16.08 | $0.47 — | |
| XOMA Royalty Corporation X0M1.F | €28.40 31.05 USD |
-2.74
|
€343.29M 375.26M USD | €13.00 14.21 USD | €28.40 31.05 USD | €28.40 31.05 USD | €343.29M 375.26M USD | 0 | -€1.23 -1.3 USD | |
| Altimmune, Inc. 3G0.F | €3.57 3.9 USD |
-0.56
|
€337.99M 369.47M USD | €800.00 874.51 USD | €3.57 3.9 USD | €3.57 3.9 USD | €337.99M 369.47M USD | 0 | -€0.92 -1.005 USD | |
| Clinuvel Pharmaceuticals Limited UR9.F | €6.15 6.72 USD |
+2.5
|
€335.42M 366.66M USD | €1.02K 1.11K USD | €6.15 6.72 USD | €6.15 6.72 USD | €335.42M 366.66M USD | 15.37 | €0.40 0.44 USD | |
| Galectin Therapeutics Inc. PHPN.F | €4.98 5.44 USD |
+1.63
|
€329.04M 359.68M USD | €2.00K 2.19K USD | €4.98 5.44 USD | €4.98 5.44 USD | €329.04M 359.68M USD | 0 | -€0.55 -0.6 USD | |
| Clinuvel Pharmaceuticals Limited UR9A.F | €5.95 6.5 USD |
0
|
€327.24M 357.71M USD | €1.68K 1.84K USD | €5.95 6.5 USD | €5.95 6.5 USD | €327.24M 357.71M USD | 14.87 | €0.40 0.44 USD | |
| Flerie AB (publ) 1NP.F | €4.16 4.55 USD |
+1.96
|
€325.60M 355.93M USD | €1.00 1.09 USD | €4.03 4.41 USD | €4.14 4.53 USD | €325.60M 355.93M USD | 0 | -€8.83 -9.6 USD | |
| Newron Pharmaceuticals S.p.A. NP5.F | €16.10 17.6 USD |
-1.23
|
€321.37M 351.3M USD | €14.70K 16.07K USD | €16.10 17.6 USD | €16.10 17.6 USD | €321.37M 351.3M USD | 11.83 | €1.36 1.49 USD | |
| Healios K.K. 6VX.F | €2.46 2.69 USD |
-0.81
|
€316.27M 345.72M USD | €350.00 382.6 USD | €2.46 2.69 USD | €2.46 2.69 USD | €316.27M 345.72M USD | 0 | -€0.34 -0.3 USD | |
| Cellectis S.A. ZVA.F | €3.17 3.47 USD |
+0.48
|
€310.97M 339.94M USD | €1.25K 1.37K USD | €3.17 3.47 USD | €3.17 3.47 USD | €310.97M 339.94M USD | 0 | -€0.28 -0.3 USD | |
| Cellectis S.A. ZVAA.F | €3.08 3.37 USD |
-1.91
|
€303.59M 331.86M USD | €1.86K 2.03K USD | €3.08 3.37 USD | €3.08 3.37 USD | €303.59M 331.86M USD | 0 | -€0.28 -0.3 USD | |
| Gongwin Biopharm Holdings Co., Ltd. 6617.TWO | NT$84.60 2.69 USD |
-2.08
|
NT$10.37B 329.63M USD | NT$185.71K 5.9K USD | NT$83.50 2.65 USD | NT$86.30 2.74 USD | NT$10.37B 329.63M USD | 0 | -NT$0.48 -0.01 USD | |
| Panacea Biotec Limited PANACEABIO.BO | ₹404.10 4.89 USD |
+1.14
|
₹27.12B 328.08M USD | ₹2.90K 35.12 USD | ₹402.30 4.87 USD | ₹413.10 5 USD | ₹27.12B 328.08M USD | 214.94 | ₹1.88 0.02 USD | |
| Panacea Biotec Limited PANACEABIO.NS | ₹404.60 4.89 USD |
+1.01
|
₹27.08B 327.67M USD | ₹62.54K 756.58 USD | ₹401.15 4.85 USD | ₹412.95 5 USD | ₹27.08B 327.67M USD | 215.21 | ₹1.88 0.02 USD | |
| Enanta Pharmaceuticals, Inc. 9EP.F | €10.10 11.04 USD |
0
|
€291.41M 318.56M USD | €54.00 59.03 USD | €10.10 11.04 USD | €10.10 11.04 USD | €291.41M 318.56M USD | 0 | -€3.73 -4.07 USD | |
| AC Immune SA IMR.F | €2.76 3.01 USD |
-3.33
|
€284.06M 310.51M USD | €2.00K 2.19K USD | €2.76 3.01 USD | €2.76 3.01 USD | €284.06M 310.51M USD | 0 | -€0.78 -0.8 USD | |
| Frontage FGHQF | $0.15 — |
0
|
$303.75M — | $130.00 — | $0.15 — | $0.15 — | $303.75M — | 0 | $0.00 — | |
| Avalo Therapeutics Inc. R C6K0.F | €13.14 14.36 USD |
-0.45
|
€276.09M 301.8M USD | €4.00 4.37 USD | €13.14 14.36 USD | €13.14 14.36 USD | €276.09M 301.8M USD | 0 | -€11.58 -12.6 USD | |
| Oryzon Genomics S.A. ORN.F | €2.84 3.1 USD |
-1.73
|
€274.31M 299.86M USD | €50.00 54.66 USD | €2.84 3.1 USD | €2.84 3.1 USD | €274.31M 299.86M USD | 0 | -€0.06 -0.06 USD | |
| Aldeyra Therapeutics, Inc. 137.F | €4.52 4.94 USD |
-0.59
|
€271.82M 297.13M USD | €540.00 590.29 USD | €4.52 4.94 USD | €4.52 4.94 USD | €271.82M 297.13M USD | 0 | -€0.63 -0.6 USD | |
| Immutep PRRUF | $0.20 — |
0
|
$294.38M — | $2.50K — | $0.22 — | $0.22 — | $294.38M — | 0 | -$0.03 — | |
| Astria Therapeutics, Inc. 2090.MU | €4.74 5.18 USD |
0
|
€267.40M 292.3M USD | €108.00 118.06 USD | €4.74 5.18 USD | €4.74 5.18 USD | €267.40M 292.3M USD | 0 | -€44.71 -48.8 USD | |
| Larimar Therapeutics, Inc. ZA71.F | €2.88 3.15 USD |
-7.1
|
€267.31M 292.21M USD | €510.00 557.5 USD | €2.88 3.15 USD | €2.88 3.15 USD | €267.31M 292.21M USD | 0 | -€1.69 -1.8 USD | |
| Hansa Biopharma AB (publ) HNSBF | $2.91 — |
0
|
$290.20M — | $150.00 — | $2.93 — | $2.93 — | $290.20M — | 0 | -$0.96 — | |
| Silence Therapeutics plc XRP2.F | €5.55 6.07 USD |
-8.26
|
€262.15M 286.56M USD | €827.00 904.02 USD | €5.55 6.07 USD | €5.55 6.07 USD | €262.15M 286.56M USD | 0 | -€1.17 -1.2 USD | |
| scPharmaceuticals Inc. 2SX.F | €4.76 5.2 USD |
0
|
€261.18M 285.51M USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €261.18M 285.51M USD | 0 | €0.00 0 USD | |
| Oryzon Genomics ORYZF | $3.61 — |
0
|
$284.66M — | $5.00K — | $3.03 — | $3.03 — | $284.66M — | 0 | -$0.07 — | |
| SELLAS Life Sciences Group, Inc. RXK3.F | €1.40 1.53 USD |
+8.22
|
€250.96M 274.33M USD | €6.12K 6.69K USD | €1.40 1.53 USD | €1.40 1.53 USD | €250.96M 274.33M USD | 0 | -€0.26 -0.2 USD | |
| ProQR Therapeutics N.V. 0PQ.F | €1.81 1.98 USD |
-0.11
|
€250.08M 273.37M USD | €758.00 828.6 USD | €1.81 1.98 USD | €1.81 1.98 USD | €250.08M 273.37M USD | 0 | -€0.41 -0.4 USD | |
| Mereo BioPharma Group plc MAH0.SG | €1.53 1.67 USD |
-1.61
|
€243.47M 266.15M USD | €0.00 0 USD | €1.53 1.67 USD | €1.54 1.68 USD | €243.47M 266.15M USD | 0 | -€0.26 -0.2 USD | |
| Onward Medical N.V. 63E.F | €4.16 4.55 USD |
+1.46
|
€243.22M 265.88M USD | €140.00 153.04 USD | €4.06 4.43 USD | €4.16 4.55 USD | €243.22M 265.88M USD | 0 | -€0.74 -0.8 USD | |
| Capricor Therapeutics, Inc. 4LN2.F | €4.96 5.42 USD |
-5.8
|
€242.29M 264.85M USD | €200.00 218.63 USD | €4.96 5.42 USD | €4.96 5.42 USD | €242.29M 264.85M USD | 0 | -€1.51 -1.6 USD | |
| Egetis Therapeutics AB (publ) P0F.SG | €0.56 0.62 USD |
+0.54
|
€241.75M 264.27M USD | €0.00 0 USD | €0.56 0.61 USD | €0.56 0.62 USD | €241.75M 264.27M USD | 0 | -€0.09 -0.09 USD | |
| Mereo BioPharma Group plc MAH0.F | €1.52 1.66 USD |
-4.11
|
€241.08M 263.54M USD | €600.00 655.88 USD | €1.52 1.66 USD | €1.52 1.66 USD | €241.08M 263.54M USD | 0 | -€0.26 -0.2 USD | |
| Egetis Therapeutics AB (publ) P0F.F | €0.53 0.58 USD |
0
|
€240.47M 262.86M USD | €20.00K 21.86K USD | €0.53 0.58 USD | €0.53 0.58 USD | €240.47M 262.86M USD | 0 | -€0.09 -0.09 USD | |
| Atrys Health, S.A. A2T.F | €2.73 2.98 USD |
-0.73
|
€238.12M 260.3M USD | €1.03K 1.12K USD | €2.51 2.74 USD | €2.73 2.98 USD | €238.12M 260.3M USD | 0 | -€0.32 -0.3 USD | |
| Hansa Biopharma AB (publ) 24H.F | €2.32 2.54 USD |
+0.69
|
€237.88M 260.04M USD | €517.00 565.15 USD | €2.32 2.54 USD | €2.32 2.54 USD | €237.88M 260.04M USD | 0 | -€0.83 -0.9 USD | |
| Eledon Pharmaceuticals, Inc. 2TK.F | €1.59 1.74 USD |
+6
|
€236.97M 259.04M USD | €1.00K 1.09K USD | €1.59 1.74 USD | €1.59 1.74 USD | €236.97M 259.04M USD | 2.83 | €0.56 0.61 USD | |
| Voyager Therapeutics, Inc. VYGR.MX | MX$78.50 4.65 USD |
0
|
MX$4.36B 258.44M USD | MX$14.94K 884.63 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$4.36B 258.44M USD | 0 | -MX$39.75 -2.3 USD | |
| Editas Medicine, Inc. 8EM.F | €2.29 2.5 USD |
-1.46
|
€235.84M 257.81M USD | €500.00 546.57 USD | €2.29 2.5 USD | €2.29 2.5 USD | €235.84M 257.81M USD | 0 | -€2.03 -2.2 USD | |
| Vicore Pharma Holding AB (publ) 6Y4.F | €0.88 0.96 USD |
-4.37
|
€232.87M 254.55M USD | €1.00K 1.09K USD | €0.88 0.96 USD | €0.88 0.96 USD | €232.87M 254.55M USD | 0 | -€0.18 -0.1 USD | |
|
Không có cổ phiếu ưa thích
Bạn chưa có cổ phiếu ưa thích nào, hãy thêm nó vào mục ưa thích để thấy nó tại đây |
||||||||||